Skip to main content
. 2021 Jul 27;9(9):1010–1020. doi: 10.1016/S2213-2600(21)00310-6

Figure 2.

Figure 2

Time to first self-reported recovery

(A) Concurrent randomisation analysis population. (B) SARS-CoV-2 PCR-positive participants in the concurrent randomisation analysis population. The concurrent randomisation analysis population was defined as all participants who were randomly assigned to usual care plus doxycycline or usual care only during the time period when the usual care plus doxycycline group was open to randomisation.